Spots Global Cancer Trial Database for oral placebo
Every month we try and update this database with for oral placebo cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012) | NCT04246177 | Carcinoma, Hepa... | Lenvatinib Pembrolizumab Oral Placebo IV Placebo TACE | 18 Years - | Merck Sharp & Dohme LLC | |
Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients | NCT03593304 | Vincristine Ind... Acute Lymphobla... | Injection Mecob... Tablet Pyridoxi... Normal saline Oral Placebo | 18 Years - 85 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study | NCT05342194 | Intrahepatic Ch... | Toripalimab Lenvatinib mesy... Placebo IV Oral placebo Oxaliplatin for... Gemcitabine hyd... Cisplatin | 18 Years - 75 Years | Shanghai Junshi Bioscience Co., Ltd. | |
Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients | NCT03593304 | Vincristine Ind... Acute Lymphobla... | Injection Mecob... Tablet Pyridoxi... Normal saline Oral Placebo | 18 Years - 85 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients | NCT03593304 | Vincristine Ind... Acute Lymphobla... | Injection Mecob... Tablet Pyridoxi... Normal saline Oral Placebo | 18 Years - 85 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients | NCT03469271 | Cancer | 1,25 (OH)2 D3 Inspiratory iso... Oral Placebo Sham Inspirator... Threshold Inspi... | 18 Years - | Mayo Clinic | |
Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet | NCT01896232 | Secondary Hyper... Chronic Kidney ... | Etelcalcetide Cinacalcet Oral Placebo Intravenous Pla... | 18 Years - 85 Years | Amgen | |
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ | NCT00952731 | Ductal Breast C... Estrogen Recept... | oral placebo afimoxifene tamoxifen citra... placebo gel | 18 Years - | Northwestern University | |
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | NCT01432015 | Ovarian Cancer Uterine Cancer | fosaprepitant aprepitant Oral Placebo IV placebo | 18 Years - | Gynecologic Oncology Associates | |
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients | NCT05558007 | Erectile Dysfun... Erectile Dysfun... Prostate Cancer Radical Prostat... | Tadalafil 5mg BZ371A Oral Placebo Topical Placebo | 40 Years - 65 Years | Biozeus Biopharmaceutical S.A. | |
Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients | NCT03593304 | Vincristine Ind... Acute Lymphobla... | Injection Mecob... Tablet Pyridoxi... Normal saline Oral Placebo | 18 Years - 85 Years | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |